Russia's cancer vaccine achieves 100% efficacy in clinical trials

Asmodeus

Well-known member
  • Feb 6, 2023
    6,871
    15,659
    113
    Ursa Major
    The article you’re referring to reports on a Russian-developed cancer vaccine called Enteromix, which has shown 100% efficacy and safety in clinical trials, according to claims from Russia’s Federal Medical and Biological Agency.

    🧬 What Is Enteromix?​

    • It’s a personalized mRNA-based cancer vaccine, similar in technology to COVID-19 vaccines.
    • It trains the immune system to recognize and eliminate cancer cells.
    • The vaccine is tailored to each patient’s RNA profile.
    • Initial applications target colorectal cancer, with versions in development for glioblastoma (brain cancer) and melanoma (skin cancer).

    🧪 Trial Results & Next Steps​

    • Clinical trials reportedly showed tumor shrinkage, slowed growth, and no serious side effects.
    • The vaccine uses four harmless viruses to attack tumors and boost immunity.
    • It’s awaiting final regulatory approval before public release.

    ⚠️ Should You Believe It?​

    While the results sound promising, it's important to note:

    • These claims come from Russian state agencies and media, and independent peer-reviewed validation is not yet available.
    • “100% efficacy” is an extraordinary claim that requires rigorous global scrutiny.
    • Until published in reputable scientific journals and reviewed internationally, it’s best to stay cautiously optimistic.


    Bing AI.